DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

company name or ticker
Company Photos
(Click to zoom)

Former Onyx CEO Returns to Biotech to Launch Boston Start Up

Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson

Novartis AG and Amgen Inc. have promising new psoriasis drugs that could challenge Johnson & Johnson's Stelara for market share.

Energy Sector Rains On Bulls' Parade, But Skies May Clear Soon

Can These Top Dividend-Paying Stocks Soar in 2015?

There's more to top dividend-paying stocks than the yield.

bluebird bio (BLUE) Soars on Data from LentiGlobin Study - Analyst Blog

Mylan Among First to Launch Generic Celebrex - Analyst Blog

Gilead Sciences Bucks Trend In Biotech Short Interest

Can Pfizer’s Cholesterol Drug Catch Up To The Competition?

Pfizer’s bococizumab remains in last place in the PCSK9 race. Will it arrive too late to make a meaningful impact on the market?

Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog

AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) - Analyst Blog

See More Articles...